Global Neonatal Ventilators Market Focused Insight 2026-2031

NEONATAL VENTILATORS MARKET SIZE & SHARE

Neonatal ventilators, also known as neo ventilators, are specialized medical devices used to provide critical respiratory support to newborn infants. The neonatal ventilators market size was valued at USD 450.00 million in 2025 and is projected to grow at a CAGR of 4.63% during the forecast period. Market growth is primarily driven by the increasing rate of preterm births, the rising prevalence of neonatal respiratory distress syndrome (RDS), and improved survival rates among extremely low birth weight infants.

The adoption of neonatal ventilators is further supported by government initiatives aimed at reducing infant mortality and expanding neonatal intensive care infrastructure worldwide. Emerging economies across regions such as Asia-Pacific, Latin America, and Africa are increasingly investing in maternal and child healthcare programs as well as NICU modernization to enhance outcomes for premature infants. In addition, initiatives led by organizations such as the World Health Organization and UNICEF are promoting the procurement of advanced ventilators in public healthcare facilities and improving access to neonatal respiratory care equipment in hospitals.

The growing preference for portable neonatal ventilators is also expected to support market expansion, particularly due to their increasing use in ambulances and short-term stabilization units. Manufacturers including Dräger, GE HealthCare, and Philips are focusing on the development of compact, multi-mode portable ventilators equipped with advanced monitoring capabilities. For example, Dräger offers the Babylog VN600, a trolley-mounted ventilator designed to support intensive neonatal care and facilitate smooth patient transitions.

THE NEONATAL VENTILATORS MARKET NEWS

• In 2025, GE HealthCare announced its acquisition of Intelerad, a leading provider of medical imaging software, in a deal valued at USD 2.3 billion. The transaction is expected to be completed during the first half of 2026 and is anticipated to strengthen GE HealthCare’s cloud-based and AI-enabled enterprise imaging capabilities by improving connectivity across hospital, outpatient, and ambulatory care settings.
• In 2024, Getinge AB launched the Servo TwinView, a web-based platform designed to enable clinicians to remotely monitor ventilator parameters and patient metrics.
• In 2024, Hamilton Medical introduced its NIV mask portfolio for non-invasive ventilation, featuring a broad range of interchangeable elbows to support different NIV therapy applications and improve treatment flexibility.

NEONATAL VENTILATORS MARKET TRENDS & ENABLERS

Shift Towards Non-Invasive & Hybrid Ventilators

The increasing integration of non-invasive ventilation technologies such as NIPPV, nasal CPAP, and high-flow nasal cannula therapy into neonatal ventilation systems is improving the delivery of respiratory support while reducing the risk of lung injury in newborns. In addition, several manufacturers are introducing advanced neonatal ventilators that combine multiple respiratory support modalities within a single platform, allowing smoother transitions based on the infant’s changing clinical condition. For example, Hamilton Medical offers the HAMILTON-C6 Neo, a ventilator specifically designed for neonatal intensive care units with advanced lung-protective ventilation features. These ongoing technological advancements are expected to drive sustained growth in the global neonatal ventilators market.

Increasing Adoption of Neurally Adjusted Ventilatory Assist

The rising adoption of Neurally Adjusted Ventilatory Assist (NAVA) is contributing to the expansion of the neonatal ventilators market as healthcare providers increasingly focus on intelligent respiratory management systems and data-driven ventilation technologies. Leading medical device manufacturers are integrating advanced technologies such as NAVA into their premium respiratory care product portfolios to strengthen their competitive positioning. For example, Servo ventilators developed by Getinge AB incorporate both NAVA and Edi monitoring technologies to continuously assess an infant’s diaphragmatic activity in real time, enabling personalized ventilatory support and smoother weaning from mechanical ventilation. These capabilities are often associated with improved neonatal outcomes and reduced NICU stays.

Growing Preterm Birth Rate

Preterm infants are at a substantially higher risk of respiratory distress, immature organ development, and long-term health complications, often requiring immediate admission to neonatal intensive care units (NICUs). According to estimates from the World Health Organization, nearly 15 million babies are born prematurely worldwide each year, and this number is expected to continue increasing in the coming years. As a result, preterm birth remains one of the most significant global public health challenges, thereby driving the demand for advanced neonatal respiratory support systems and supporting growth in the neonatal ventilators market.

SEGMENTATION INSIGHTS

Insights By Component

Based on component, the global neonatal ventilators market is segmented into devices and consumables & accessories. In 2025, the consumables & accessories segment accounted for the largest revenue share, contributing over 60% of the market, primarily due to the frequent and high-volume use of disposable and short-life respiratory components in neonatal intensive care units (NICUs).

Meanwhile, the devices segment is expected to register a significant growth rate of approximately 3% during the forecast period, driven by rising investments in NICU infrastructure and the growing adoption of advanced invasive and non-invasive neonatal ventilators across healthcare facilities.

Insights By Functionality

Based on functionality, the global neonatal ventilators market is segmented into non-invasive ventilation systems. Non-invasive neonatal ventilators account for the largest market share and are expected to continue experiencing strong growth during the forecast period.

This growth is primarily driven by the increasing preference among clinicians for lung-protective respiratory support strategies, lower risk of intubation-related complications, and improved clinical outcomes in newborn infants.

Insights By Mobility

Based on mobility, the global neonatal ventilators market is segmented into standalone and portable ventilators. Standalone ventilators account for a significant share of the market due to their advanced functionality, comprehensive monitoring systems, and ability to support multiple ventilation modes.

Meanwhile, portable ventilators are expected to witness notable growth during the forecast period, driven by the increasing adoption of respiratory care solutions in home healthcare settings, ambulatory clinics, and community health centers.

Insights By End-User

Based on end-user, the global neonatal ventilators market is segmented into hospitals, maternity & specialty care centers, and others. Hospitals accounted for the largest share of market revenue in 2025, primarily due to the high number of neonatal admissions, increasing incidence of complex respiratory conditions, and the continuous demand for advanced ventilation support in critical care settings.

In addition, maternity and specialty care centers are expected to witness strong growth during the forecast period as these facilities continue to expand their NICU capabilities and increasingly adopt non-invasive and hybrid ventilators to provide early-stage respiratory support for newborns.

GEOGRAPHICAL ANALYSIS

In 2025, North America emerged as the largest regional market for neonatal ventilators, with the United States accounting for a dominant share across the region. Market growth in the country is supported by high institutional delivery rates, well-established healthcare infrastructure, and strong adoption of technology-enabled neonatal care solutions.

The European neonatal ventilators market is also witnessing steady growth, supported by the presence of major regional manufacturers such as Drägerwerk AG & Co. KGaA and Löwenstein Medical SE & Co. KG. The strong presence of these companies is contributing to ongoing technology upgrades and increasing adoption of advanced neonatal ventilation systems across healthcare facilities in the region.

Asia-Pacific is projected to be the fastest-growing regional market for neonatal ventilators during the forecast period. Growth in the region is driven by rising healthcare investments, expanding NICU infrastructure, and increasing awareness regarding neonatal respiratory care. China remains a major contributor to regional growth, while India is emerging as one of the fastest-growing markets due to supportive government initiatives such as the Rashtriya Bal Swasthya Karyakram and Ayushman Bharat, which are strengthening neonatal healthcare intervention and referral systems. In addition, the increasing adoption of remote NICU monitoring and tele-NICU models is further supporting market expansion across the region.

Furthermore, countries including Brazil, Mexico, Argentina, United Arab Emirates, and Saudi Arabia are making substantial investments in healthcare infrastructure, which is gradually supporting demand for neonatal ventilators.

VENDOR LANDSCAPE

The global neonatal ventilators market is highly competitive and comprises several international and regional players, including Dräger, Hamilton Medical, Getinge AB, GE HealthCare, and Philips, among others. These companies hold substantial market shares due to their strong product portfolios, continuous technological innovations, and strategic initiatives aimed at strengthening their competitive positions. Market participants are increasingly focusing on product advancements, partnerships, collaborations, and mergers and acquisitions with technology providers and suppliers to expand their neonatal care capabilities.

For example, in 2025, Dräger announced the expansion of its neonatal care portfolio through the integration of BiliPredics, an advanced software solution developed by NeoPredics, aimed at enhancing neonatal care management and clinical decision support.